Adicet Bio Inc expected to post a loss of 69 cents a share - Earnings Preview

ADICET Bio

11/03/2024 11:01

* Adicet Bio Inc  ACET.OQ   ACET.O  is expected to show a
rise in
quarterly revenue when it reports  results on March 13
(estimated) for the period ending December 31 2023
    * The Boston Massachusetts-based  company is expected to
report
revenue of $625 thousand, according to the mean estimate from 8
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Adicet Bio Inc is for a
loss
of 69 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Adicet Bio
Inc is
$8.00​, above​ its last closing price of $2.43. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.78       -0.74      -1.16     Missed  -57.3
 Jun. 30 2023  -0.71       -0.68      -0.75     Missed  -10
 Mar. 31 2023  -0.71       -0.69      -0.72     Missed  -4.8​
 Dec. 31 2022  0.29        -0.28      -0.72     Missed  -158.1
 ​​Sep.        -0.55       -0.53      -0.53     Met     -0.6
 30 2022                                                
 Jun. 30 2022  -0.44       -0.45      -0.56     Missed  -23.1​
 Mar. 31 2022  -0.24       -0.18      0.10      Beat    154.9
 Dec. 31 2021  -0.25       -0.42      -0.47     Missed  -11.6
 This summary was machine generated March 11 at 11:01 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)